Industry Verticals »

All Categories

Insights »

About TMR »

Subcutaneous Immunoglobulin Market

Subcutaneous Immunoglobulin Market (Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases; End User - Hospitals, Clinics, and Home Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global subcutaneous immunoglobulin market for the historical period 2017–2018 and forecast period 2019–2027, Rise in prevalence of autoimmune disorders, Increase in global geriatric population, Growing usage in off-label indications are projected to drive the global subcutaneous immunoglobulin market during the forecast period
  • According to the report, the global subcutaneous immunoglobulin market was valued at US$ 4.0 Bn in 2018 and is anticipated to expand at a CAGR of 13.1% from 2019 to 2027
fa global subcutaneous immunoglobulins market

To know the scope of our report Get a Sample on Subcutaneous Immunoglobulin Market 

Rise in Prevalence of Autoimmune Disorders and Increase in Global Geriatric Population to Increase the Demand of Subcutaneous Immunoglobulin: Key Drivers

  • The global subcutaneous immunoglobulin market continues to expand at a high growth rate due to increasing prevalence of autoimmune diseases such as primary humoral immunodeficiency (PIDD), multiple sclerosis, immune thrombocytopenia purpura (ITP), autoimmune hemolytic anemia, and Kawasaki syndrome. For instance, According to the Immune Deficiency Foundation (IDF), in 2018, approximately 1 people per 4,000 in the U.S. suffer from primary immunodeficiency and there are over 5 million undiagnosed cases in the U.S. alone.
  • Prevalence of several diseases such as cancer, diabetes, and neurological disorders is rising due to rapidly increasing geriatric population. The geriatric population is more vulnerable to diseases due to poor immunity.
  • According to the World Health Organization, the global geriatric population is likely to reach around 2 billion (22% of global population) by 2050 as against 900 million in 2015. Countries such as India, China, Thailand, and South Korea are also expected to have large geriatric populations in the shortest span of time in the near future.

Get a glimpse of the in-depth analysis through our Report Brochure

Growing Subcutaneous Immunoglobulin Usage in Off-label Indications and Technological Advancement Boost Market Growth

  • The steady increase in the use of immunoglobulin for treatment of off-label indications is expected to drive the market during the forecast period. Common off-label indications treated with intravenous immunoglobulin are Guillain-Barre syndrome, multifocal motor neuropathy, dermatomyositis, polymyositis, stiff person syndrome, and relapsing-remitting multiple sclerosis, among others
  • Technological improvements in the production and purification methods of intravenous and subcutaneous immunoglobulin (SCIG) have made these safer and free from protein, viral, or any other contaminants. This has increased clinician preference for usage of IVIG and SCIG. This in turn is expected to boost demand for subcutaneous immunoglobulin.

 High Cost of Treatment and Supply Demand Gaps to Hamper Market

  • Cost of plasma collection and manufacturing processes is high as compared to materials and processes used in the manufacture of traditional pharmaceutical products. Moreover, being a blood derived component, highly sophisticated collection, purification, and storage methods are required for subcutaneous immunoglobulin (SCIG) products.
  • Due to fewer market players and the time gap between plasma collection and getting the product in the market, SCIG production becomes a tedious and time-consuming process, if not managed properly can hamper the subcutaneous immunoglobulin (SCIG) market during the forecast period.

 Global Subcutaneous immunoglobulin Market: Competitive Landscape

  • This report profiles major players in the global subcutaneous immunoglobulin market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global subcutaneous immunoglobulin market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global subcutaneous immunoglobulin market are
    • Biotest AG
    • CSL Limited
    • Grifols
    • S.A.  
    • Kedrion S.p.A
    • Octapharma AG
    • Takeda Pharmaceutical Company Limited
    • Bio Products Laboratory Ltd.
    • LFB S.A. .

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Subcutaneous immunoglobulin Market: Key Developments

Key players in the global subcutaneous immunoglobulin market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global subcutaneous immunoglobulin market. A few expansion strategies adopted by players operating in the global subcutaneous immunoglobulin market are:

  • In March 2019, Takeda Pharmaceutical Company Limited received U.S. FDA approval to manufacture flexbumin at new plasma manufacturing facility near Covington, Georgia
  • In July 2019, Grifols S.A. received the USFDA approval for Xembify for treatment of primary immunodeficiencies.
  • In September 2018, CSL Behring received the Australian Therapeutic Goods Administration (TGA) approval for Hizentra for treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)

The report on the global subcutaneous immunoglobulin market discussed individual strategies, followed by company profiles of manufacturers of subcutaneous immunoglobulin. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global subcutaneous immunoglobulin market.

Global Subcutaneous Immunoglobulins Market - Segmentation

Application

Primary Immunodeficiency Diseases

Secondary Immunodeficiency Diseases

Others

End-user

Hospital

Clinic

Home Care Setting

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of subcutaneous immunoglobulin market?

Subcutaneous immunoglobulin market to reach US$ 12.2 Bn by 2027

What is the anticipated CAGR of the subcutaneous immunoglobulin market in the forecast period?

Subcutaneous immunoglobulin market is anticipated to expand at a CAGR of 13.1% from 2019 to 2027

What are the key driving factors for the growth of the subcutaneous immunoglobulin market?

Subcutaneous immunoglobulin market is driven by rise in prevalence of autoimmune disorders and increase in global geriatric population

Which region is expected to project the highest market share in the global subcutaneous immunoglobulin market?

North America accounted for major share of the global subcutaneous immunoglobulin market

Who are the key players in the global subcutaneous immunoglobulin market?

Key players in the global subcutaneous immunoglobulin market include Biotest AG, CSL Limited, Grifols, S.A. Kedrion S.p.A., Octapharma AG, Takeda Pharmaceutical Company Limited

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Subcutaneous immunoglobulins Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Application Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Subcutaneous immunoglobulins Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Development in the Market

        5.2. Key Success Factors for Top 3 Market Players

        5.3. Mergers & Acquisitions 

    6. Global Subcutaneous immunoglobulins Market Analysis and Forecast, by Application

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Subcutaneous immunoglobulins Market Value Forecast, by Application, 2017–2027

            6.2.1. Primary Immunodeficiency Diseases 

            6.2.2. Secondary Immunodeficiency Diseases 

            6.2.3. Others

        6.3. Global Subcutaneous immunoglobulins Market Attractiveness, by Application

    7. Global Subcutaneous immunoglobulins Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Subcutaneous immunoglobulins Market Value Forecast, by End-user, 2017–2027

            7.2.1. Hospital

            7.2.2. Clinic

            7.2.3. Others

        7.3. Global Subcutaneous immunoglobulins Market Attractiveness, by End-user

    8. Global Subcutaneous immunoglobulins Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Subcutaneous immunoglobulins Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. North America Subcutaneous immunoglobulins Market Attractiveness, by Region

    9. North America Subcutaneous immunoglobulins Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027

            9.2.1. Primary Immunodeficiency Diseases 

            9.2.2. Secondary Immunodeficiency Diseases 

            9.2.3. Others

        9.3. North America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            9.3.1. Hospital

            9.3.2. Clinic

            9.3.3. Others

        9.4. North America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Subcutaneous immunoglobulins Market Attractiveness Analysis 

            9.5.1. By Application

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Subcutaneous immunoglobulins Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027

            10.2.1. Primary Immunodeficiency Diseases 

            10.2.2. Secondary Immunodeficiency Diseases 

            10.2.3. Others

        10.3. Europe Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            10.3.1. Hospital

            10.3.2. Clinic

            10.3.3. Others

        10.4. Europe Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe 

        10.5. Europe Subcutaneous immunoglobulins Market Attractiveness Analysis 

            10.5.1. By Application

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Subcutaneous immunoglobulins Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027

            11.2.1. Primary Immunodeficiency Diseases 

            11.2.2. Secondary Immunodeficiency Diseases 

            11.2.3. Others

        11.3. Asia Pacific Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            11.3.1. Hospital

            11.3.2. Clinic

            11.3.3. Others

        11.4. Asia Pacific Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific 

        11.5. Asia Pacific Subcutaneous immunoglobulins Market Attractiveness Analysis 

            11.5.1. By Application

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Subcutaneous immunoglobulins Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027

            12.2.1. Primary Immunodeficiency Diseases 

            12.2.2. Secondary Immunodeficiency Diseases 

            12.2.3. Others

        12.3. Latin America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            12.3.1. Hospital

            12.3.2. Clinic

            12.3.3. Others

        12.4. Latin America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America Latin America 

        12.5. Latin America Subcutaneous immunoglobulins Market Attractiveness Analysis 

            12.5.1. By Application

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Subcutaneous immunoglobulins Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027

            13.2.1. Primary Immunodeficiency Diseases 

            13.2.2. Secondary Immunodeficiency Diseases 

            13.2.3. Others

        13.3. Middle East & Africa Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            13.3.1. Hospital

            13.3.2. Clinic

            13.3.3. Others

        13.4. Middle East & Africa Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa 

        13.5. Middle East & Africa Subcutaneous immunoglobulins Market Attractiveness Analysis 

            13.5.1. By Application

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis, by Company, 2019

        14.3. Company Profiles

            14.3.1. Biotest AG 

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Financial Analysis

                14.3.1.3. Growth Strategies

                14.3.1.4. SWOT Analysis

            14.3.2. CSL Limited (CSL Behring) 

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Financial Analysis

                14.3.2.3. Growth Strategies

                14.3.2.4. SWOT Analysis

            14.3.3. Grifols, S.A. 

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Financial Analysis

                14.3.3.3. Growth Strategies

                14.3.3.4. SWOT Analysis

            14.3.4. Kedrion S.p.A. 

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Financial Analysis

                14.3.4.3. Growth Strategies

                14.3.4.4. SWOT Analysis

            14.3.5. Octapharma AG 

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Financial Analysis

                14.3.5.3. Growth Strategies

                14.3.5.4. SWOT Analysis

            14.3.6. Takeda Pharmaceutical Company Limited 

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Financial Analysis

                14.3.6.3. Growth Strategies

                14.3.6.4. SWOT Analysis

            14.3.7. Bio Products Laboratory Ltd. 

                14.3.7.1.  Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Financial Analysis

                14.3.7.3. Growth Strategies

                14.3.7.4. SWOT Analysis

            14.3.8. LFB S.A. 

                14.3.8.1.  Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Financial Analysis

                14.3.8.3. Growth Strategies

                14.3.8.4. SWOT Analysis

            14.3.9. Other prominent Players

    List of Table

    Table 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 02: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 03: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Region, 2017–2027

    Table 04: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017-2027

    Table 05: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 06: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 07: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 08: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 09: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 10: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017-2027

    Table 11: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 12: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 13: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017-2027

    Table 14: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017-2027

    Table 15: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 16: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2017-2027

    Table 17: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2017-2027

    Table 18: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    List of Figure

    Figure 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2019–2027

    Figure 02: Market Value Share, by Application (2018)

    Figure 03: Market Value Share, by End-user (2018)

    Figure 04: Market Value Share, by Region (2018)

    Figure 05: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2018 and 2027

    Figure 06: Global Subcutaneous Immunoglobulin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Primary Immunodeficiency Diseases, 2017–2027

    Figure 07: Global Subcutaneous Immunoglobulin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secondary Immunodeficiency Diseases, 2017–2027

    Figure 08: Global Subcutaneous Immunoglobulin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 09: Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application, 2019-2027

    Figure 10: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 11: Global SCIG Market Revenue (US$ Mn), by Hospitals, 2017–2027

    Figure 12: Global SCIG Market Revenue (US$ Mn), by Clinics, 2017–2027

    Figure 13: Global SCIG Market Revenue (US$ Mn), by Home Care, 2017–2027

    Figure 14: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user, 2019-2027

    Figure 15: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Region, 2018 and 2027

    Figure 16: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Region

    Figure 17: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2017–2027

    Figure 18: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country, 2019-2027

    Figure 19: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2018 and 2027

    Figure 20: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 21: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country, 2018 and 2027

    Figure 22: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application, 2017–2025

    Figure 23: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user, 2017–2025

    Figure 24: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 25: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 26: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2018 and 2027

    Figure 27: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 28: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 29: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application, 2019-2027

    Figure 30: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user, 2019-2027

    Figure 31: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2017–2027

    Figure 32: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 33: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2018 and 2027

    Figure 34: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 35: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 36: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application, 2017–2025

    Figure 37: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user, 2017–2025

    Figure 38: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 39: Latin America SCIG Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 40: Latin America SCIG Market Value Share Analysis, by Application, 2018 and 2027

    Figure 41: Latin America SCIG Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 42: Latin America SCIG Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 43: Latin America SCIG Market Attractiveness Analysis, by Application, 2019-2027

    Figure 44: Latin America SCIG Market Attractiveness Analysis, by End-user, 2019-2027

    Figure 45: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 46: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 47: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2018 and 2027

    Figure 48: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 49: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 50: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application, 2019–2027

    Figure 51: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 52: Global Subcutaneous Immunoglobulin (SCIG) Market Share Analysis, by Company (2019)

Copyright © Transparency Market Research, Inc. All Rights reserved

Subcutaneous Immunoglobulin Market

Schedule a Call